Petros Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
Petros Pharmaceuticals has a total shareholder equity of $3.1M and total debt of $7.2M, which brings its debt-to-equity ratio to 232.5%. Its total assets and total liabilities are $20.7M and $17.6M respectively.
Key information
232.5%
Debt to equity ratio
US$7.25m
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.89m |
| Equity | US$3.12m |
| Total liabilities | US$17.58m |
| Total assets | US$20.69m |
Recent financial health updates
Recent updates
It's Probably Less Likely That Petros Pharmaceuticals, Inc.'s (NASDAQ:PTPI) CEO Will See A Huge Pay Rise This Year
Nov 13
Petros Pharmaceuticals GAAP EPS of -$0.10, revenue of $6.6M
Aug 15Petros Pharma shares more than triple in value after co to be taken private in $67.2M deal
Jul 28Petros Pharmaceuticals: Advancing Complementary Men's Health Therapeutics
Dec 07Financial Position Analysis
Short Term Liabilities: PTPI's short term assets ($10.7M) do not cover its short term liabilities ($12.6M).
Long Term Liabilities: PTPI's short term assets ($10.7M) exceed its long term liabilities ($5.0M).
Debt to Equity History and Analysis
Debt Level: PTPI's net debt to equity ratio (107.6%) is considered high.
Reducing Debt: PTPI's debt to equity ratio has reduced from 407.7% to 232.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PTPI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PTPI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.5% each year